Evaluate

July 26, 2022

Move over Aduhelm, it’s tofersen’s turn

March 31, 2022

Amylyx’s chances rest on a knife edge

September 16, 2021

Biogen leads the amyotrophic lateral sclerosis hopefuls

Despite several recent late-stage failures, there is still a lot going on in the ALS pipeline.